Robert Beauchamp
Principal Investigator
Last active: 10/31/2018

  1. Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer. Tedesco KL, Berlin J, Blanke CD, Teng M, Choy H, Roberts J, Beauchamp RD, Leach S, Wyman K, Tarpley J, Shyr Y, Caillouette C, Chakravarthy B (2005) Int J Radiat Oncol Biol Phys 61(5): 1364-70
    › Primary publication · 15817338 (PubMed)
  2. E-cadherin is regulated by the transcriptional repressor SLUG during Ras-mediated transformation of intestinal epithelial cells. Schmidt CR, Gi YJ, Patel TA, Coffey RJ, Beauchamp RD, Pearson AS (2005) Surgery 138(2): 306-12
    › Primary publication · 16153441 (PubMed)
  3. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD (2005) J Clin Invest 115(7): 1765-76
    › Primary publication · 15965503 (PubMed) · PMC1150288 (PubMed Central)
  4. Cell proliferation: a matter of time and place. Deane NG, Parker MA, Beauchamp RD (2005) Surgery 138(1): 1-7
    › Primary publication · 16003308 (PubMed)
  5. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Halder SK, Beauchamp RD, Datta PK (2005) Neoplasia 7(5): 509-21
    › Primary publication · 15967103 (PubMed) · PMC1501161 (PubMed Central)
  6. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells. Mithani SK, Balch GC, Shiou SR, Whitehead RH, Datta PK, Beauchamp RD (2004) J Surg Res 117(2): 296-305
    › Primary publication · 15047135 (PubMed)
  7. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer. Lawson LL, Sandler M, Martin W, Beauchamp RD, Kelley MC (2004) Am Surg 70(12): 1050-5; discussion 1055-6
    › Primary publication · 15663043 (PubMed)
  8. Oncogenic Ras dominates overexpression of E-cadherin in malignant transformation of intestinal epithelial cells. Schmidt CR, Gi YJ, Coffey RJ, Beauchamp RD, Pearson AS (2004) Surgery 136(2): 303-9
    › Primary publication · 15300195 (PubMed)
  9. Enhanced tumor formation in cyclin D1 x transforming growth factor beta1 double transgenic mice with characterization by magnetic resonance imaging. Deane NG, Lee H, Hamaamen J, Ruley A, Washington MK, LaFleur B, Thorgeirsson SS, Price R, Beauchamp RD (2004) Cancer Res 64(4): 1315-22
    › Primary publication · 14973059 (PubMed)
  10. Department of Surgery, Vanderbilt University Medical Center, Nashville, Tenn. Beauchamp RD (2004) Arch Surg 139(8): 814-5
    › Primary publication · 15302687 (PubMed)